Company / Accounts Receivable
JRSIS HEALTH CARE Corp Accounts Receivable History
FY2014-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Accounts Receivable
$714.7K
FY2023
5-year range
$683.5K / $8.2M
FY2019-FY2023
Trend
+4.6%
vs FY2022
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Accounts Receivable returned to growth in FY2023 after 2 years of decline, reaching $714,658.
Based on SEC 10-K filings.
$714,658 in FY2023 with a 5-year CAGR of -38.6%.
Declined from $8M to $714,658 over the past 2 years.
Accounts Receivable over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -38.6%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -38.6%, indicating a declining trend.
- In FY2023, accounts receivable increased 4.6% year-over-year.
- Peak accounts receivable was recorded in FY2018.
- Lowest accounts receivable in the period was in FY2014.
Company context
Key Data Points
- Altman Z-Score -0.20 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Accounts ReceivableValue | YoY GrowthYoY |
|---|---|---|
| FY2023 | $714.7K | +4.6% |
| FY2022 | $683.5K | -90.9% |
| FY2021 | $7.5M | -8.1% |
| FY2018 | $8.2M | +44.6% |
| FY2017 | $5.7M | +70.3% |
| FY2016 | $3.3M | +66.0% |
| FY2015 | $2.0M | +203.7% |
| FY2014 | $661.7K | - |
As of FY2023 · SEC 10-K · Updated Jun 29, 2026